Skip to content

Molecular and Cellular Analysis of Breast Cancer

Molecular and Cellular Analysis of Breast Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02243397
Enrollment
145
Registered
2014-09-17
Start date
2014-09-10
Completion date
2021-04-19
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast - Female, Breast - Male

Brief summary

The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Minutes to No maximum
Healthy volunteers
No

Inclusion criteria

1. Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy. 2. 18 years of age or older. 3. Ability to understand and the willingness to sign a written informed consent do

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
levels of GM-CSF in plasma10 yearsWe will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026